Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at [email protected] Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

No More Offline Filings: CDSCO Mandates Submission of Post-Approval Changes for Cell and Gene Therapy Trial via SUGAM Portal

Phase 3 trial initiated for Ifinatamab Deruxtecan in Pretreated Metastatic Castration-Resistant Prostate Cancer: Merck, Daiichi Sankyo

Written By Ruchika Sharma19 Jun 2025 10:00 AM IST

Basking Ridge: Merck and Daiichi Sankyo have announced that the first patient has been dosed in the IDeate-Prostate01 phase 3 trial evaluating...

Govt extends deadline for submitting applications under PLI Scheme

DoP extends deadline for submitting applications under PLI Scheme for pharma sector

Written By Ruchika Sharma18 Jun 2025 5:45 PM IST

New Delhi: The Department of Pharmaceuticals (DoP), Ministry of Chemicals & Fertilizers, has extended the deadline for submitting...

Medtonic to invest nearly Rs 430 crore in new diabetes GCC in Pune

Written By Ruchika Sharma18 Jun 2025 2:03 PM IST

Pune: In a major boost to India's growing healthcare tech scene, global medical device giant Medtronic plc has announced plans to...

JnJ wins USFDA approval for subcutaneous Rybrevant Faspro for EGFR-Mutated NSCLC

JnJ seeks USFDA nod of Stelara for pediatric Crohn's disease

Written By Ruchika Sharma18 Jun 2025 11:58 AM IST

Horsham: Johnson & Johnson is seeking the U.S. Food and Drug Administration (FDA) approval for the expansion of STELARA (ustekinumab) for the...

Quadria Capital-Led Consortium Eyes Majority Stake in Samarth Lifesciences at Rs 4,500 Cr Valuation

Eli Lilly to buy Verve Therapeutics for USD 1.3 billion

Written By Ruchika Sharma17 Jun 2025 5:40 PM IST

Indianapolis: Eli Lilly and Company and Verve Therapeutics have announced a definitive agreement for Lilly to acquire Verve for USD 1.3...

India continues to be a leading supplier of vaccines: Anupriya Patel

Written By Ruchika Sharma17 Jun 2025 4:19 PM IST

New Delhi:; India continues to be a leading supplier of vaccines, with 70 per cent of WHO's total vaccines being sourced from India. This was...

Bayer Finerenone approved in Japan for chronic heart failure

Bayer seeks USFDA nod for Gadoquatrane for contrast enhanced magnetic resonance imaging of CNS

Written By Ruchika Sharma17 Jun 2025 12:44 PM IST

Berlin: Bayer has announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for its...

Roche Q1 Sales Dip 5% on Currency Headwinds, Pins Hopes on New Drugs, Weight-Loss Entry

Roche to proceed with Phase III development of Prasinezumab in early-stage Parkinson's disease

Written By Ruchika Sharma17 Jun 2025 11:00 AM IST

Basel: Roche has announced its decision to proceed with Phase III development of prasinezumab, an investigational anti-alpha-synuclein antibody,...

Lupin Launches Bioequivalent of Xigduo XR in US Across Multiple Strengths

Lupin partners with SUP to bring Tiotropium DPI to COPD patients in China

Written By Ruchika Sharma16 Jun 2025 11:46 AM IST

Mumbai: Global pharma major Lupin Limited has signed a supply and license agreement with Sino Universal Pharmaceuticals (SUP), for...

SII, DNDi collaborate on new Dengue treatment for low, middle income countries

Written By Ruchika Sharma16 Jun 2025 11:00 AM IST

SII will also be responsible for manufacturing, development and providing clinical supplies of monoclonal antibodies.

Syngene International, Bristol Myers Squibb Extend Strategic Collaboration Through 2035

Syngene International gets USFDA EIR for Bengaluru GMP manufacturing facilities

Written By Ruchika Sharma16 Jun 2025 10:15 AM IST

Karnataka: Syngene International has announced that the Company has received Establishment Inspection Report (EIR) from US Food and Drugs...

Merck Keytruda approved by USFDA for Advanced Head and Neck Cancer

Written By Ruchika Sharma15 Jun 2025 2:30 PM IST

Rahway: Merck, known as MSD outside of the United States and Canada, has announced that the U.S. Food and Drug Administration (FDA) has approved...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok